BRSR for FY25-26 filed with KPMG limited assurance
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India filed its Business Responsibility and Sustainability Report for FY25-26 with limited assurance from KPMG. Standalone turnover was about 22,756 million rupees, exports contributed 5.2 percent, and net worth stood at about 8,728 million rupees. The company has 760 permanent employees and ceased manufacturing during the year, leaving no permanent workers. Board has 5 of 6 women directors. Customer complaints stood at 37 with 3 pending resolution. The filing is a routine annual ESG disclosure mandated under SEBI listing regulations.
Routine annual ESG compliance filing with no material business impact. Reaffirms governance and sustainability disclosures for shareholders.